Although the exact mechanism of endoxifen inhibition in melanoma is unclear, it is believed that endoxifen exerts its effect in part via estrogen receptor (ER), in a similar manner to tamoxifen in ER-positive breast cancer cells. The gene discussed is ESR1; the disease is melanoma.